Alzheimer's Disease Clinical Trials

Alzheimer's Disease

This is a research study to look at the safety and effectiveness of an investigational drug for mild to moderate Alzheimer's disease.  Participants will receive the study drug or a placebo (a pill with no medication) and undergo tests that check attention, concentration, and memory.  Adults with mild to moderate Alzheimer's disease who are on a stable dose of donepezil for at least 4 months maybe eligible to participate.

Participants will receive payment for each completed visit.  The investigational drug or placebo and tests are provided at no cost.  For more information contact Stephanie Nolting at (513) 558-7183 or stephanie.nolting@uc.edu.